News

Net Loss of Genomic Valley Biotech reported to Rs 0.01 crore in the quarter ended March 2026 as against net loss of Rs 0.08 crore during the previous quarter ended March 2025. Sales declined 84.62% to Rs 0.04 crore in the quarter ended March 2026 as against Rs 0.26 crore during the previous quarter ended March 2025.For the full year,net profit declined 91.67% to Rs 0.03 crore in the year ended March 2026 as against Rs 0.36 crore during the previous year ended March 2025. Sales declined 67.86% to Rs 0.27 crore in the year ended March 2026 as against Rs 0.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales0.040.26 -85 0.270.84 -68 OPM %03.85 -14.8153.57 - PBDT00.01 -100 0.040.45 -91 PBT00.01 -100 0.040.45 -91 NP-0.01-0.08 88 0.030.36 -92 Powered by Capital Market - Live News

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Genomic Valley Biotech declined 93.75% to Rs 0.01 crore in the quarter ended December 2025 as against Rs 0.16 crore during the previous quarter ended December 2024. Sales declined 77.27% to Rs 0.05 crore in the quarter ended December 2025 as against Rs 0.22 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.050.22 -77 OPM %20.0072.73 - PBDT0.010.16 -94 PBT0.010.16 -94 NP0.010.16 -94 Powered by Capital Market - Live News

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 15 January 2026.Powered by Capital Market - Live News

Genomic Valley Biotech announced that the 31th Annual General Meeting(AGM) of the company will be held on 31 December 2025.Powered by Capital Market - Live News